Lynch Syndrome & Endometrial Cancer — What It Means for You and Your Family
Most endometrial cancer is not inherited. But a meaningful minority is, and when it is, the cause is usually Lynch syndrome — an inherited fault in the genes that proofread DNA when cells divide. Two things make it worth understanding properly. First, in women with Lynch syndrome, endometrial cancer is very often the first cancer to appear — before any bowel cancer, sometimes by years. That makes an endometrial diagnosis a genuine opportunity to identify the syndrome while it can still change what happens next. Second, it is inherited in a pattern where each close relative has a one-in-two chance of carrying it — so identifying it in one woman can protect a whole family.
- It is uncommon but consequential — a minority of endometrial cancers, but the finding changes surveillance for life
- Often the first Lynch cancer in women — the uterus frequently announces the syndrome before the bowel does
- CION tests every tumour — mismatch repair status is checked on every endometrial cancer as standard, not on request
- It matters to your relatives — each parent, sibling and child has a one-in-two chance of carrying the same variant
on Panel
Survival Rate*
Treated
(800+ reviews)
What Lynch Syndrome Actually Is
Every time a cell divides it copies three billion letters of DNA, and it makes mistakes. A set of genes called the mismatch repair genes act as proofreaders, finding those errors and correcting them. Lynch syndrome means being born with one working copy and one faulty copy of one of these genes.
One working copy is enough for normal life, which is why people with Lynch syndrome are healthy and usually have no idea they carry it. The difficulty arises when, by chance, a cell loses its remaining working copy. That cell can no longer proofread, errors accumulate rapidly, and cancer becomes far more likely than it would otherwise be. The tissues most affected are those whose linings divide frequently — the bowel and the endometrium.
- It is inherited dominantly. Each child of a person with Lynch syndrome has a one-in-two chance of inheriting the same variant. It does not skip generations, and it passes through fathers as readily as mothers.
- It raises risk substantially, not to certainty. The lifetime risk of endometrial and bowel cancer is much higher than average, but many carriers never develop either — particularly with surveillance.
- Cancers tend to appear younger. Lynch-related endometrial cancer often occurs before the menopause, at ages where sporadic endometrial cancer is uncommon.
- Several genes are involved. Which gene is affected influences how high the risk is and which cancers dominate, so the plan is individual rather than one-size-fits-all.
Lynch is not the only hereditary route to endometrial cancer — Cowden syndrome is another, rarer one. But it is by far the most common, and the one every endometrial cancer is screened for.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
How Lynch Syndrome Is Identified
The route runs from the tumour to the blood, not the other way round, and only the last step is a genetic test in the sense most people mean.
| Step | What happens | What it means |
|---|---|---|
| 1. Tumour testing | The tissue already removed at biopsy or surgery is tested for mismatch repair proteins, or for the instability pattern their loss produces. No extra procedure, no extra sample. At CION this is done on every endometrial cancer. | A normal result makes Lynch syndrome unlikely and the pathway usually stops. An abnormal result means the proofreading system failed in this tumour — which is common, and not yet a diagnosis of Lynch. |
| 2. Distinguishing the cause | Most abnormal results are caused by a chemical switch that silences one gene in the tumour alone. A further test on the same tissue checks for this. | If that switch explains it, the cause is confined to the tumour and is not inherited. This accounts for the majority of abnormal results. |
| 3. Genetic counselling | If the tumour result is not explained by that switch, you are offered genetic counselling — a discussion of what testing would and would not tell you, and what it would mean for relatives. | Nothing is tested without this conversation, and proceeding is your decision. See what genetic counselling involves. |
| 4. Germline testing | A blood sample examines the mismatch repair genes in your normal cells rather than the tumour. See the genetic testing process. | This is what confirms or excludes Lynch syndrome, and what relatives can then be tested for directly. |
The step people most often misunderstand is the second one. An abnormal tumour result is common and usually turns out not to be inherited. Being told your tumour is mismatch repair deficient is not the same as being told you have Lynch syndrome — see MMR / MSI-H testing explained.
Ask Whether Lynch Testing Applies to You
Whether you have been diagnosed, or a relative has and you are wondering what it means for you. Genetic counselling available at our Hyderabad centres.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
One Test Can Protect a Whole Family
Identifying Lynch syndrome in one person lets everyone related to them find out where they stand — and act on it.
What a Lynch Diagnosis Changes
It changes four things — and, importantly, it does not usually change the treatment of the cancer you already have.
Bowel Surveillance
Regular colonoscopy is the single most valuable consequence. It finds and removes polyps before they become cancer, and in Lynch syndrome it demonstrably reduces bowel cancer deaths. See surveillance if you have Lynch syndrome and our colon cancer service.
Immunotherapy Eligibility
Tumours with failed mismatch repair respond notably well to immunotherapy, which matters if disease is advanced or recurrent. See immunotherapy for MMR-deficient disease.
Risk-Reducing Surgery
For women who have completed their families, removing the uterus and ovaries largely removes the gynaecological risk. Timing is individual. See risk-reducing hysterectomy.
Testing for Relatives
Once the exact variant is known, relatives can be tested for that one change specifically — simpler, quicker and cheaper. See Lynch syndrome and your family.
Wider Awareness
Ovarian, gastric, urinary tract and some skin cancers occur more often, at levels that vary by gene. Surveillance is tailored rather than uniform.
Your Current Treatment
Surgery, and whether radiotherapy or drug treatment is advised, are decided mainly by stage and grade. A Lynch result rarely alters the plan for early-stage disease — its value is mostly forward-looking.
A Relative Has Lynch Syndrome. What About Me?
If a family member has been diagnosed, testing for you is targeted and straightforward. Bring their report if you have it — the consultation is free.
Hereditary Endometrial Cancer — The Full Picture
Each page covers one part of the genetics story, from the tumour test through to what it means for your relatives.
- Signs your endometrial cancer could be Lynch-related
- MMR / MSI-H testing explained — what it means for you
- Genetic testing for Lynch syndrome — the process
- Lynch syndrome & your family (parents, siblings, children)
- Cancer surveillance if you have Lynch syndrome
- Lynch syndrome — endometrial & colorectal cancer together
- Cowden syndrome & endometrial cancer
- Is endometrial cancer hereditary? (mostly not — the myth)
- What genetic counselling for endometrial cancer involves
- Risk-reducing hysterectomy for Lynch syndrome
- Preventing cancer with Lynch syndrome (surveillance & aspirin)
- Family history & endometrial cancer risk
Why This Is Something CION Does Directly
Hereditary cancer needs the tumour test, the counselling and the surveillance to connect. When those sit in three different institutions, they usually do not.
Scan and biopsy in one visit
MMR / MSI testing as standard
Tumour board for every diagnosis
Named MCh surgical oncologists
45-minute consultations
Decisions for healing, not billing
You Deserve to Know Whether This Runs in Your Family
For most women the answer is no. For the minority where it is yes, knowing changes what happens for the next generation.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Lynch Syndrome & Endometrial Cancer — Frequently Asked Questions
My tumour came back MMR deficient. Does that mean I have Lynch syndrome?
Not by itself, and this is the single most common misunderstanding. Mismatch repair deficiency simply means the proofreading system failed in that tumour, and there are two quite different reasons it can fail. The common one is a chemical switch that silences a repair gene in the tumour tissue alone — not inherited, not passed to children, and accounting for the majority of abnormal results. The rare one is an inherited fault present in every cell, which is Lynch syndrome. A further test on the same tissue usually distinguishes them, and only if that test does not explain the result is germline testing offered.
Nobody in my family has had cancer. Can I still have Lynch syndrome?
Yes, and this is precisely why testing is no longer limited to women with a striking family history. Small families, families with few women, families where relatives died young of other causes, and families where a diagnosis was never discussed can all conceal an inherited pattern. Inheritance through the father is also frequently missed, because people look for uterine cancer in their mother\u0027s line. Studies that tested every endometrial tumour rather than only selected ones found a meaningful number of Lynch cases that family-history criteria would have missed entirely.
If I have Lynch syndrome, will my children definitely get cancer?
No. Two separate things need to be true, and neither is certain. First, each child has a one-in-two chance of inheriting the variant — half will not, and those children carry no raised risk and cannot pass anything on. Second, inheriting it raises cancer risk substantially but does not guarantee cancer; many carriers never develop one, particularly with surveillance. What inheriting it does guarantee is access to a programme — colonoscopy from an earlier age, gynaecological awareness, and choices about risk-reducing surgery later — that removes much of the danger.
Should my children be tested now?
Usually not in childhood. Because Lynch-related cancers occur in adulthood and surveillance begins in adulthood, testing children provides no medical benefit while removing their ability to make the decision themselves. Standard practice is to offer testing in early adult life, timed so that a positive result leads straight into a surveillance programme. There is no single correct age, and genetic counselling exists partly to work through that with each family. What is worth doing now is making sure your adult relatives know the finding exists and can seek advice.
I have Lynch syndrome but no cancer. Should I have my uterus removed?
It is a reasonable option for some women and the wrong one for others, which is why it is a discussion rather than a recommendation. Removing the uterus and ovaries largely removes the gynaecological cancer risk, and for a woman who has completed her family and is approaching the menopause the balance often favours it. For a younger woman it means surgical menopause, with consequences for bone health, cardiovascular risk and quality of life that have to be weighed and managed. The alternative — symptom awareness and prompt investigation of any abnormal bleeding — is genuinely effective, because this cancer bleeds early.
Medical disclaimer: This page is general health information, reviewed by a CION oncologist. It cannot tell you whether you or your family carry an inherited cancer predisposition — only genetic counselling and testing can do that. If you have been told a tumour is mismatch repair deficient, or a relative has been diagnosed with Lynch syndrome, please seek genetic counselling rather than relying on any website.